Federal Register / Vol. 61, No. 109 / Wednesday, June 5, 1996 / Notices 28597

et seq. (‘‘the Act’’), the National Center

for Manufacturing Sciences, Inc.

(‘‘NCMS’’) has filed written notifications

simultaneously with the Attorney

General and the Federal Trade

Commission disclosing changes in its

membership and providing information

on the status of its research projects.

The notifications were filed for the

purpose of extending the Act’s

provisions limiting the recovery of

antitrust plaintiffs to actual damages

under specified circumstances.

Specifically, the following company was

accepted as an active member of NCMS:

Vacuum Instrument Corporation,

Ronkonkoma, NY. The following

organizations were also approved for

affiliate membership: Forging Industry

Association, Cleveland, OH; Iowa State

University, Ames, IA; Michigan State

University, E. Lansing, MI; ORTECH

Corporation, Mississauga, Ontario,

Canada and The University of Michigan,

College of Engineering, Ann Arbor, MI.

The following companies have resigned

from active membership in NCMS:

AlliedSignal Inc., Morristown, NJ;

Franklin Consulting, Ltd., Troy, MI;

Groupe Procycle Inc., St. Georges,

Quebec, Canada and Labbe Designers &

Inc., Montreal, Quebec. The following

organization has resigned from affiliate

membership in NCMS: Texas State

Technical College, Waco, TX.

No other changes have been made in

either the membership or planned

activity of the group research project.

Membership in this group research

project remains open, and NCMS

intends to file additional written

notification disclosing all changes in

membership.

On February 20, 1987, NCMS filed its

original notification pursuant to section

6(a) of the Act. The Department of

Justice published a notice in the Federal

Register pursuant to section 6(b) of the

Act on March 17, 1987 (52 FR 8375).

The last notification was filed with

the Department on February 16, 1996.

This notice was published in the

Federal Register on April 8, 1996 (61 FR

15521).

Constance K. Robinson,

Director of Operations, Antitrust Division.

[FR Doc. 96–14068 Filed 6–4–96; 8:45 am]

BILLING CODE 4410–01–M

Notice Pursuant to the National

Cooperative Research and Production

Act of 1993; Southwest Research

Institute Transguide System Media

Services Software Project; Correction

In notice document 95–29504

appearing on page 62262 in the issue of

Tuesday, December 5, 1995, in the first

column, in the first full paragraph, in

the 25th line, the words ‘‘San Antonio,

TX’’ should be deleted.

Constance K. Robinson,

Director of Operations, Antitrust Division.

[FR Doc. 96–14072 Filed 6–4–96; 8:45 am]

BILLING CODE 4410–01–M

Notice Pursuant to the National

Cooperative Research and Production

Act of 1993; Southwest Research

Institute Transguide System Media

Services Software Project

Notice is hereby given that, on March

8, 1996, pursuant to section 6(a) of the

National Cooperative Research and

Production Act of 1993, 15 U.S.C. 4301

et seq. (‘‘the Act’’), the Southwest

Research Institute, on behalf of the

Transguide System Media Services

Software Project, has filed written

notifications simultaneously with the

Attorney General and the Federal Trade

Commission disclosing changes in its

membership. The notifications were

filed for the purpose of extending the

Act’s provisions limiting the recovery of

antitrust plaintiffs to actual damages

under specified circumstances.

Specifically, the changes are as follows:

Metro Networks Ltd., San Antonio, TX

has been added to the venture.

On August 23, 1995, the Southwest

Research Institute, on behalf of the

Transguide System Media Services

Software Project, filed its original

notification pursuant to section 6(a) of

the Act. The Department of Justice

published a notice in the Federal

Register pursuant to section 6(b) of the

Act on December 5, 1995 (60 FR 62262).

Constance K. Robinson,

Director of Operations, Antitrust Division.

[FR Doc. 96–14073 Filed 6–4–96; 8:45 am]

BILLING CODE 4410–01–M

Notice Pursuant to the National

Cooperative Research and Production

Act of 1993—Switched Multi-Megabit

Data Service Interest Group

Notice is hereby given that, on March

6, 1996, pursuant to section 6(a) of the

National Cooperative Research and

Production Act of 1993, 15 U.S.C. 4301

et seq. (‘‘the Act’’), the Switched MultiMegabit Data Service Interest Group

(‘‘the Group’’) has filed written

notifications simultaneously with the

Attorney General and the Federal Trade

Commission disclosing changes to its

membership. The notifications were

filed for the purpose of extending the

Act’s provisions limiting the recovery of

antitrust plaintiffs to actual damages

under specified circumstances.

Specifically, the identity of the new

member to the Group is Cascade

Communications Corporation, Westford,

MA.

No other changes have been made in

either the membership or planned

activity of the group research project.

Membership in this group research

project remains open, and the Group

intends to file additional written

notifications disclosing all changes in

membership.

On April 19, 1991, the Group filed its

original notification pursuant to section

6(a) of the Act. The Department of

Justice published a notice in the Federal

Register pursuant to section 6(b) of the

Act on May 23, 1991, (56 FR 23723).

The last notification was filed with the

Department on June 23, 1994. A notice

was published in the Federal Register

pursuant to section 6(b) of the Act on

September 26, 1994, (59 FR 49084).

Constance K. Robinson,

Director of Operations, Antitrust Division.

[FR Doc. 96–14070 Filed 6–4–96; 8:45 am]

BILLING CODE 4410–01–M

Drug Enforcement Administration

Manufacturer of Controlled

Substances; Correction

On March 4, 1996, a Notice of

Application for Johnson Matthey, Inc.

(Johnson Matthey), Custom

Pharmaceuticals Department, 2003

Nolte Drive, West Deptford, New Jersey

08066, was published in the Federal

Register requesting registration as a bulk

manufacturer of Schedules I and II

controlled substances. See 61 FR 8303.

The notice invited that comments or

objections be filed by May 3, 1996. A

correction was subsequently published

on April 10, 1996, adding

dihydrocodeine (9120) and meperidine

(9230) to the list of controlled

substances that Johnson Matthey made

application to manufacture in bulk. See

61 FR 15974. Comments regarding

Johnson Matthey’s application for

dihydrocodeine and meperidine must

be filed by June 10, 1996.

It has come to the Drug Enforcement

Administration’s (DEA) attention that

Johnson Matthey does not wish to be

registered as a bulk manufacturer of

meperidine. Therefore, meperidine is

hereby deleted from the list of

controlled substances for which Johnson

Matthey made application to

manufacture in bulk. However, the list

of controlled substances for which

Johnson Matthey has applied to

manufacture in bulk should have

included thebaine (9333) and alfentanil

(9737).
28598 Federal Register / Vol. 61, No. 109 / Wednesday, June 5, 1996 / Notices

Any other such applicant and any

person who is presently registered with

DEA to manufacture thebaine and

alfentanil may file comments or

objections to the issuance of the above

application.

Any such comments or objections

may be addressed, in quintuplicate, to

the Deputy Assistant Administrator,

Office of Diversion Control, Drug

Enforcement Administration, United

States Department of Justice,

Washington, DC 20537, Attention: DEA

Federal Register Representative (CCR),

and must be filed no later than (60 days

from publication).

Dated: May 28, 1996.

Gene R. Haislip,

Deputy Assistant Administrator, Office of

Diversion Control, Drug Enforcement

Administration.

[FR Doc. 96–14058 Filed 6–4–96; 8:45 am]

BILLING CODE 4410–09–M

Manufacturer of Controlled

Substances; Application

Pursuant to § 1301.43(a) of Title 21 of

the Code of Federal Regulations (CFR),

this is notice that on April 22, 1996,

Penick Corporation, 158 Mount Olivet

Avenue, Newark, New Jersey 07114,

made application to the Drug

Enforcement Administration (DEA) for

registration as a bulk manufacturer of

the basic classes of controlled

substances listed below:

Drug Schedule

Tetrahydrocannabinols (7370) .......... I

Dihydromorphine (9145) .................... I

Pholcodine (9314) ............................. I

Methylphenidate (1724) ..................... II

Coca Leaves (9040) .......................... II

Cocaine (9041) .................................. II

Codeine (9050) .................................. II

Dihydrocodeine (9120) ...................... II

Oxycodone (9143) ............................. II

Hydromorphone (9150) ..................... II

Diphenoxylate (9170) ........................ II

Benzoylecgonine (9180) .................... II

Ethylmorphine (9190) ........................ II

Hydrocodone (9193) .......................... II

Meperidine (9230) ............................. II

Methadone (9250) ............................. II

Methadone-intermediate (9254) ........ II

Dextropropoxyphene, bulk (non-dosage forms) (9273).II

Morphine (9300) ................................ II

Thebaine (9333) ................................ II

Opium, raw (9600) ............................ II

Opium extracts (9610) ....................... II

Opium fluid extract (9620) ................. II

Opium tincture (9630) ....................... II

Opium powdered (9639) ................... II

Opium granulated (9640) .................. II

Levo-alphacetylmethadol (9648) ....... II

Opium poppy (9650) ......................... II

Oxymorphone (9652) ........................ II

Drug Schedule

Poppy Straw Concentrate (9670) ...... II

Alfentanil (9737) ................................ II

Sufentanil (9740) ............................... II

Fentanyl (9801) ................................. II

The firms plans to manufacture the

listed controlled substances for

distribution as bulk pharmaceutical

products to its customers.

Any other such applicant and any

person who is presently registered with

DEA to manufacture such substances

may file comments or objections to the

issuance of the above application.

Any such comments or objections

may be addressed, in quintuplicate, to

the Deputy Assistant Administrator,

Office of Diversion Control, Drug

Enforcement Administration, United

States Department of Justice,

Washington, DC 20537, Attention: DEA

Federal Register Representative (CCR),

and must be filed no later than August

5, 1996.

Dated: May 22, 1996.

Gene R. Haislip,

Deputy Assistant Administrator, Office of

Diversion Control, Drug Enforcement

Administration.

[FR Doc. 96–14057 Filed 6–4–96; 8:45 am]

BILLING CODE 4410–09–M

Importer of Controlled Substances;

Registration

By Notice dated March 27, 1996, and

published in the Federal Register on

April 4, 1996, (61 FR 15121), Radian

Corporation, 8501 Mopac Blvd., PO Box

201088, Austin, Texas 78720, made

application to the Drug Enforcement

Administration (DEA) to be registered as

an importer of the basic classes of

controlled substances listed below:

Drug: Schedule

Ibogaine (7260) ................................. I

Etorphine (except HCL) (9056) ......... I

Heroin (9200) .................................... I

Cocaine (9041) .................................. II

Codeine (9050) .................................. II

Oxycodone (9143) ............................. II

Dextropropoxyphene, bulk (non-dosage forms) (9273).II

Morphine (9300) ................................ II

Thebaine (9333) ................................ II

Oxymorphone (9652) ........................ II

No comments or objections have been

received. DEA has considered the

factors in Title 21, United States Code,

section 823(a) and determined that the

registration of Radian Corporation to

import the listed controlled substances

is consistent with the public interest

and with United States obligations

under international treaties,

conventions, or protocols in effect on

May 1, 1971, at this time. Therefore,

pursuant to section 1008(a) of the

Controlled Substances Import and

Export Act and in accordance with Title

21, Code of Federal Regulations,

§ 1311.42, the above firm is granted

registration as an importer of the basic

classes of controlled substances listed

above.

Dated: May 23, 1996.

Gene R. Haislip,

Deputy Assistant Administrator, Office of

Diversion Control, Drug Enforcement

Administration.

[FR Doc. 96–14059 Filed 6–4–96; 8:45 am]

BILLING CODE 4410–09–M

Immigration and Naturalization Service

[INS No. 1776–96]

Discontinuation of the Nicaraguan

Review Process

AGENCY: Immigration and Naturalization

Service, Justice.

ACTION: Notice.

SUMMARY: This notice announces the

extension until June 12, 1997, of the

transitional work authorization criteria

to be applied to applications filed by

Nicaraguans affected by the termination

of the Nicaraguan Review Program

(NRP) on June 13, 1995. The extension

of these criteria is designed to afford

Nicaraguans affected by the termination

of the NRP, who have yet to file a

motion to reopen their deportation

proceedings to apply for suspension of

deportation as well as those who will

not have met the seven-years physical

presence requirement for suspension of

deportation by June 12, 1996, the

opportunity to benefit from these

transitional criteria.

EFFECTIVE DATE: June 5, 1996.

FOR FURTHER INFORMATION CONTACT:

Robert A. Jacobson, Director, Policy

Development and Special Programs

Branch, Detention and Deportation

Division, Immigration and

Naturalization Service, 425 I Street,

NW., Room 3008, Washington, DC

20536, telephone (202) 514–2871.

SUPPLEMENTARY INFORMATION:

Background

In a Federal Register Notice dated

June 13, 1995, 60 FR 31168, the INS

announced the termination of the

Nicaraguan Review Program. The INS

advised that Nicaraguans affected by the

termination of the NRP, i.e. certain

Nicaraguans who are subject to orders of